Literature DB >> 2391500

The nucleotide sequence of the equine herpesvirus 4 thymidine kinase gene.

L Nicolson1, A A Cullinane, D E Onions.   

Abstract

We have determined the genomic location and nucleotide sequence of the equine herpesvirus 4 thymidine kinase (TK) gene. The gene is positioned at approximately 0.48 map units within the long unique component of the genome and is flanked by genes encoding a herpes simplex virus 1 (HSV-1) UL24 homologue and glycoprotein H. The predicted protein is composed of 352 amino acids, has an Mr of 38,800 and exhibits 36% identity to the predicted TK of HSV-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391500     DOI: 10.1099/0022-1317-71-8-1801

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Isolation and partial characterization of equine herpesvirus type 1 in Czechia.

Authors:  D Molinková; V Celer; P Jahn
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  Location and characterization of the bovine herpesvirus type 4 thymidine kinase gene; comparison with thymidine kinase genes of other herpesviruses.

Authors:  P Lomonte; M Bublot; P P Pastoret; E Thiry
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Analysis of the nucleotide sequence of five genes at the left end of the unique short region of the equine herpesvirus 4 genome.

Authors:  H S Nagesha; B S Crabb; M J Studdert
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  DNA sequence of a gene cluster in the equine herpesvirus-4 genome which contains a newly identified herpesvirus gene encoding a membrane protein.

Authors:  M P Riggio; D E Onions
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  The nucleotide sequence of asinine herpesvirus 3 glycoprotein G indicates that the donkey virus is closely related to equine herpesvirus 1.

Authors:  N Ficorilli; M J Studdert; B S Crabb
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.